These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 11305869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM.
    Acta Neuropathol Commun; 2015 Nov 10; 3():70. PubMed ID: 26556230
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M, Drukarch B, Hofstee M, Brevé J, Jongenelen CA, Bol JG, Wilhelmus MM.
    J Neurochem; 2015 Sep 10; 134(6):1116-28. PubMed ID: 26088696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R, Calero M, Piccardo P, Farlow MR, Unverzagt FW, Méndez E, Jiménez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B.
    Acta Neuropathol; 2000 Jul 10; 100(1):1-12. PubMed ID: 10912914
    [Abstract] [Full Text] [Related]

  • 7. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
    Xiong M, Wang C, Gratuze M, Saadi F, Bao X, Bosch ME, Lee C, Jiang H, Serrano JR, Gonzales ER, Kipnis M, Holtzman DM.
    Mol Neurodegener; 2023 Mar 16; 18(1):17. PubMed ID: 36922879
    [Abstract] [Full Text] [Related]

  • 8. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
    van Helmond Z, Miners JS, Kehoe PG, Love S.
    Brain Pathol; 2010 Mar 16; 20(2):468-80. PubMed ID: 19725829
    [Abstract] [Full Text] [Related]

  • 9. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M, Murray ME, Frank RD, Shinohara M, DeTure M, Yamazaki Y, Tachibana M, Atagi Y, Davis MD, Liu CC, Zhao N, Painter MM, Petersen RC, Fryer JD, Crook JE, Dickson DW, Bu G, Kanekiyo T.
    Acta Neuropathol; 2016 Aug 16; 132(2):225-234. PubMed ID: 27179972
    [Abstract] [Full Text] [Related]

  • 10. Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy.
    Sakai K, Boche D, Carare R, Johnston D, Holmes C, Love S, Nicoll JA.
    Acta Neuropathol; 2014 Dec 16; 128(6):777-89. PubMed ID: 25195061
    [Abstract] [Full Text] [Related]

  • 11. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
    Am J Pathol; 1999 Sep 16; 155(3):853-62. PubMed ID: 10487842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
    Xu F, Vitek MP, Colton CA, Previti ML, Davis J, Van Nostrand WE.
    J Alzheimers Dis; 2012 Sep 16; 31(2):359-69. PubMed ID: 22635103
    [Abstract] [Full Text] [Related]

  • 14. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E, Portelius E, Toomey CE, Blennow K, Zetterberg H, Lashley T, Brinkmalm G.
    Neurosci Lett; 2019 May 14; 701():125-131. PubMed ID: 30807796
    [Abstract] [Full Text] [Related]

  • 15. The interaction of amyloid-beta with ApoE.
    Carter DB.
    Subcell Biochem; 2005 May 14; 38():255-72. PubMed ID: 15709483
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A, Yamamoto T, Shimizu K, Ugawa Y, Nishizawa M, Takahashi H, Kakita A.
    J Neuropathol Exp Neurol; 2012 Aug 14; 71(8):750-9. PubMed ID: 22805778
    [Abstract] [Full Text] [Related]

  • 17. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC, Eigenhuis KN, Morrema THJ, van der Schors RC, van Nierop P, Bugiani M, Li KW, Hoozemans JJM, Smit AB, Rozemuller AJM.
    Acta Neuropathol Commun; 2018 Jun 04; 6(1):46. PubMed ID: 29860944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L, Petyuk VA, Tasaki S, Boyle PA, Gaiteri C, Schneider JA, De Jager PL, Bennett DA.
    JAMA Neurol; 2019 Jul 01; 76(7):818-826. PubMed ID: 31009033
    [Abstract] [Full Text] [Related]

  • 20. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
    Olichney JM, Hansen LA, Hofstetter CR, Lee JH, Katzman R, Thal LJ.
    Arch Neurol; 2000 Jun 01; 57(6):869-74. PubMed ID: 10867785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.